SCHEMBL24088111

SCHEMBL24088111

N#Cc1c(C(F)(F)F)cc(=O)[nH]c1[SiH3]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 14/20 0.53
▸ ALDH1A1 P00352 13/20 0.53
▸ GAA P10253 12/20 0.53
▸ GLA P06280 12/20 0.53
▸ HPGD P15428 9/20 0.53
▸ TP53 P04637 1/20 0.53
▸ POLB P06746 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ KMT2A Q03164 4/20 0.46
▸ HTT P42858 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ AR P10275 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ UPP1 Q16831 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20339237 0.79 KDM4E (0.57) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20350815 0.77 KDM4E (0.68) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20339496 0.72 KDM4E (0.70) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20350855 0.72 KDM4E (0.59) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20340123 0.70 KDM4E (0.67) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20339508 0.69 KDM4E (1.00) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL562812 0.69 KDM4E (1.00) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20340016 0.68 KDM4E (0.64) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20340182 0.68 KDM4E (0.64) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20340095 0.68 KDM4E (0.77) KDM4EALDH1A1GAAGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885GAA 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback